One-year post-transplant hyperglycemia aggravated kidney function in diabetic patients

2016 ◽  
Vol 120 ◽  
pp. S43
Author(s):  
Takako Yonemoto ◽  
Hiroshi Hatakeyama ◽  
Kouhei Saitoh ◽  
Chika Kyo ◽  
Rieko Umayahara ◽  
...  
Pharmaceutics ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 413
Author(s):  
Theerawut Klangjareonchai ◽  
Natsuki Eguchi ◽  
Ekamol Tantisattamo ◽  
Antoney J. Ferrey ◽  
Uttam Reddy ◽  
...  

Hyperglycemia after kidney transplantation is common in both diabetic and non-diabetic patients. Both pretransplant and post-transplant diabetes mellitus are associated with increased kidney allograft failure and mortality. Glucose management may be challenging for kidney transplant recipients. The pathophysiology and pattern of hyperglycemia in patients following kidney transplantation is different from those with type 2 diabetes mellitus. In patients with pre-existing and post-transplant diabetes mellitus, there is limited data on the management of hyperglycemia after kidney transplantation. The following article discusses the nomenclature and diagnosis of pre- and post-transplant diabetes mellitus, the impact of transplant-related hyperglycemia on patient and kidney allograft outcomes, risk factors and potential pathogenic mechanisms of hyperglycemia after kidney transplantation, glucose management before and after transplantation, and modalities for prevention of post-transplant diabetes mellitus.


2021 ◽  
Vol 39 (S2) ◽  
Author(s):  
S. Choquet ◽  
A. Lavaud ◽  
I. Boussen ◽  
D. Roos‐Weil ◽  
V. Morel ◽  
...  

2005 ◽  
Vol 5 (12) ◽  
pp. 2922-2928 ◽  
Author(s):  
Didier Ducloux ◽  
Amir Kazory ◽  
Dominique Simula-Faivre ◽  
Jean-Marc Chalopin

2016 ◽  
Vol 2016 ◽  
pp. 1-6 ◽  
Author(s):  
Akiko Takenouchi ◽  
Ayaka Tsuboi ◽  
Miki Kurata ◽  
Keisuke Fukuo ◽  
Tsutomu Kazumi

Background/Aims. Subclinical atherosclerosis and long-term glycemic variability have been reported to predict incident chronic kidney disease (CKD) in the general population. However, these associations have not been investigated in patients with type 2 diabetes with preserved kidney function.Methods. We prospectively followed up 162 patients with type 2 diabetes (mean age, 62.3 years; 53.6% men) and assessed whether carotid intima-media thickness (IMT) measured by B-mode ultrasound and visit-to-visit HbA1c variability are associated with deterioration of CKD (incident CKD defined as estimated GFR [eGFR] < 60 mL/min/1.73 m2and progression of CKD stages) over a median follow-up of 6.0 years. At baseline, 25 patients (15.4%) had CKD. Cox proportional hazards regression models were used for identifying associated factors of CKD deterioration.Results.Estimated GFR decreased from75.8±16.3to67.4±18.2 mL/min/1.73 m2(p<0.01). Of 162 patients, 32 developed CKD and 8 made a progression of CKD stages. Multivariate Cox regression analysis revealed that carotid IMT (HR: 4.0, 95% CI: 1.1–14.226.7, andp=0.03) and coefficient of variation of HbA1c (HR: 1.12, 95%: 1.04–1.21, andp=0.003) were predictors of deterioration of CKD independently of age, mean HbA1c, urinary albumin/creatinine ratio, baseline eGFR, uric acid, and leucocyte count.Conclusions.Subclinical atherosclerosis and long-term glycemic variability predict deterioration of chronic kidney disease (as defined by incident or worsening CKD) in type 2 diabetic patients with preserved kidney function.


2016 ◽  
Vol 30 (7) ◽  
pp. 802-809 ◽  
Author(s):  
Christina Dörje ◽  
Anna Varberg Reisaeter ◽  
Dag Olav Dahle ◽  
Geir Mjøen ◽  
Karsten Midtvedt ◽  
...  

2018 ◽  
Vol 14 (11) ◽  
pp. S26-S27
Author(s):  
David Romero Funes ◽  
David Gutierrez Blanco ◽  
Camila Ortiz Gomez ◽  
Rama Ganga ◽  
Emanuele Lo Menzo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document